Polyrizon PLRZ
NASDAQ PLRZ
$10.30 -0.19 (-1.81%)
As of: Aug 21, 2026 · 3:34 PM EDT

Polyrizon (PLRZ) Payables (2023 - 2025)

Polyrizon's (PLRZ) quarterly Payables came in at $294000.0 in Q4 2025, up 36.11% YoY from $216000.0 in Q4 2024, and up 18.07% on a QoQ basis from $249000.0 in Q2 2025.

Polyrizon (PLRZ) Payables (2023 - 2025) Analysis & Trends

Polyrizon (PLRZ) has 3 years of Payables data on file, last reported at $294000.0 in Q4 2025.

  • Quarterly Payables rose 36.11% year-over-year to $294000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $294000.0 (up 36.11% YoY) and the FY2025 annual result came in at $294000.0, up 36.11% from the prior year.
  • Payables climbed to $294000.0 in Q4 2025, from $249000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $358000.0 in Q4 2023 to a low of $216000.0 in Q4 2024.
  • A 3-year average of $279250.0 and a median of $271500.0 in 2025 frame the typical range for Payables.
  • Annual changes were most pronounced in 2024 — Payables plunged 39.66% — and 2025, when it surged 36.11%.
  • Tracing PLRZ's Payables over 3 years: stood at $358000.0 in 2023, then tumbled by 39.66% to $216000.0 in 2024, then surged by 36.11% to $294000.0 in 2025.
  • The last three Payables figures came in at $294000.0 (Q4 2025), $249000.0 (Q2 2025), and $216000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 167.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 470.30 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 108.02 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 622.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 428.93 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 35.57 Mn
10 Polyrizon 7.27 Mn -4.22 Mn - 294,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 294,000.00
Jun 30, 2025 249,000.00
Dec 31, 2024 216,000.00
Dec 31, 2023 358,000.00